Role of macrophages and miRNA in regulating lung macrophage polarization and lung pathogenesis during respiratory virus-induced acute lung injury in normal and diabetic Syrian hamsters.
正常和糖尿病叙利亚仓鼠呼吸道病毒引起的急性肺损伤期间巨噬细胞和 miRNA 在调节肺巨噬细胞极化和肺部发病机制中的作用。
基本信息
- 批准号:10701207
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-08-01 至 2027-07-31
- 项目状态:未结题
- 来源:
- 关键词:2019-nCoVAcute Lung InjuryAcute Respiratory Distress SyndromeAdenovirus ProteinAdenovirusesAffectAlveolar MacrophagesAnimal ModelAnti-Inflammatory AgentsBlood GlucoseBronchopneumoniaCOVID-19COVID-19 severityCellsCessation of lifeClinicalCommunicable DiseasesComparative StudyDataDevelopmentDiabetes MellitusDietDiseaseDisease OutbreaksEtiologyFatty acid glycerol estersFunctional disorderFutureGene ExpressionGeneral PopulationGenesGlycolysisGoalsHamstersHospital MortalityHospitalizationHumanImmune responseImpairmentIn VitroIncidenceIndividualInfectionInfection preventionInflammationInflammatoryInflammatory ResponseInfluenzaInfluenza A Virus, H1N1 SubtypeInnate Immune ResponseLungLung infectionsMacrophageMediatingMesocricetus auratusMetabolicMetabolic DiseasesMetabolic PathwayMicroRNAsModelingMolecularMorbidity - disease rateNon-Insulin-Dependent Diabetes MellitusOutcomePathogenesisPathogenicityPatientsPatternPhenotypePlayPneumoniaProductionProteomicsPulmonary InflammationReportingRepressionResistanceResolutionRiskRodentRoleSARS coronavirusSARS-CoV-2 infectionSeasonsSignal RepressionSignal Transduction PathwayStructureSystemTestingTherapeuticTherapeutic AgentsTherapeutic InterventionVeteransViralViral PathogenesisViral Respiratory Tract InfectionVirusVirus Diseasescandidate identificationcell growth regulationchemokinecomparativecoronavirus diseasecytokinedesigndiabeticdiabetic patienteffective therapyexperimental studyhigh riskimmune cell infiltrateimmunoregulationin vivoinfluenza virus straininnovationlung injurymetabolomicsmortalitymultiple omicsnew therapeutic targetnon-diabeticnovelnovel therapeutic interventionpandemic diseasepermissivenesspreventprototypepulmonary functionrespiratoryrespiratory virusresponsesingle-cell RNA sequencingsugartranscriptomicsvirologywestern diet
项目摘要
Over 25% of US Veterans have diabetes, and those Veterans are at an increased risk of hospitalization
and increased morbidity/mortality following severe respiratory viral infections, such as, influenza (H1N1), SARS-
CoV-2 (COVID) and adenovirus (Ad). Infection with these respiratory viruses causes acute lung injury (ALI) that
can result in acute respiratory distress syndrome (ARDS), with a mortality rate of ~40%. There are few
therapeutic options for ALI/ARDS. Virus induced ALI/ARDS is driven primarily by uncontrolled inflammatory
responses. Alveolar macrophages both induce and resolve ALI/ARDS, based on their polarization/inflammatory
state. The plasticity of macrophages to vary between pro-inflammatory (M1, pro-ALI/ARDS) and anti-
inflammatory (M2, anti-ALI/ARDS) phenotypes is driven by their metabolic states. Diabetes is a metabolic
disorder in which levels of blood glucose are high and glycolysis is the preferred cellular metabolic pathway.
Macrophages from diabetic patients have a high rate of glycolysis and an increased M1 phenotype. In addition,
macrophages from diabetic patients have a lower rate of plasticity to change from M1 to M2 because of this shift
to glycolysis. One possibility is that this glycolytic shift contributes to severe outcomes from respiratory viral
infections in diabetic patients.
The Syrian hamster is naturally permissive for influenza, SARS-CoV-2 and Ad (in contrast to other
rodents that require viral adaptation). In addition, the Syrian hamster can naturally become diabetic with a high
fat/high sugar diet. Ad14p1 is an emergent strain of Ad14 that has caused outbreaks of severe respiratory illness
and ALI/ARDS throughout the world. Hamster infection with Ad14p1 results in a patchy bronchopneumonia, as
seen in other severe human viral respiratory infections. In contrast, the prototype strain of Ad14 induces little
lung inflammation. Other studies have shown that cells dying from Ad14 infection induce an M2-like human
macrophage response, while cells dying from Ad14p1 infection fail to change M1 alveolar macrophages to an
M2 phenotype. This dying infected cell activity is regulated by the expression of the Ad gene, E1B 20K. Cells
infected by Ad14 produced sufficient E1B 20K to repolarize M1 macrophages to M2, while Ad14p1 infection does
not produce sufficient E1B 20K, and the infected cells fail to alter M1 macrophage polarization. Therefore, the
hamster model of Ad14p1 ALI/ARDS provides an appropriate system to study how diabetes affects macrophage
polarization and pathogenesis during severe viral respiratory infections. The long-term goal of this project is to
understand how emergent viruses regulate macrophage polarization to develop novel therapeutic strategies to
drive macrophage polarization to an ALI/ARDS resolving phenotype in both diabetic and non-diabetic Veterans.
To achieve this goal, a multi-omics approach will be used to identify and phenotype macrophages in
normal and diabetic hamsters infected with Ad14p1. Transcriptomics using single-cell RNA sequencing will use
gene expression profiles at the resolution of individual cells to identify and phenotype macrophages and their
polarization states. Infiltrating immune cells and other lung resident cells will also be identified. Proteomics will
be used to identify cytokines and chemokines that drive Ad14p1 pathogenesis. Metabolomics will be used to
understand the unique metabolic changes in the lungs during Ad14p1 infection in diabetes and how those
changes affect macrophage polarization. Comparative virology studies with infection of normal and diabetic
hamsters with a pandemic strain of H1N1 influenza will be used to determine whether similar mechanisms of
pathogenesis are involved in ALI/ARDS pathogenesis induced by other severe respiratory viruses. Finally, we
will test the role of miRNA expression during prototype Ad14 and Ad14p1 infection in regulating macrophage
polarization and pathogenesis, with the goals of defining mechanisms of immunomodulation and identifying
candidate miRNAs that might be used as therapeutic agents against viral ALI/ARDS.
超过25%的美国退伍军人患有糖尿病,这些退伍军人住院的风险增加
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jay R Radke其他文献
Jay R Radke的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jay R Radke', 18)}}的其他基金
Development of antibodies to specific cell surface markers to assess macrophage polarization during Adenovirus 14 and 14p1 infection in the Syrian hamster
开发针对特定细胞表面标记物的抗体,以评估叙利亚仓鼠腺病毒 14 和 14p1 感染期间的巨噬细胞极化
- 批准号:
10725702 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Modernization of Small Animal Caging for infectious disease studies at the Boise VAMC
博伊西 VAMC 用于传染病研究的小动物笼舍现代化
- 批准号:
10734738 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Role of miR-181a-5p in Adenovirus 14p1 induced Acute Lung Injury
miR-181a-5p在腺病毒14p1诱导的急性肺损伤中的作用
- 批准号:
10448747 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Role of miR-181a-5p in Adenovirus 14p1 induced Acute Lung Injury
miR-181a-5p在腺病毒14p1诱导的急性肺损伤中的作用
- 批准号:
10621862 - 财政年份:2022
- 资助金额:
-- - 项目类别:
相似海外基金
Treatment of Acute Lung Injury and Acute Respiratory Distress Syndrome
急性肺损伤和急性呼吸窘迫综合征的治疗
- 批准号:
8429041 - 财政年份:2011
- 资助金额:
-- - 项目类别:
Analysis of extravascular lung water dynamics and exhaustive evaluation of pulmonary epithelial metabolites to establish a novel therapeutic approach for acute lung injury/ acute respiratory distress syndrome
分析血管外肺水动力学和详尽评估肺上皮代谢物,以建立急性肺损伤/急性呼吸窘迫综合征的新治疗方法
- 批准号:
22592023 - 财政年份:2010
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (C)
OBSERVATIONAL STUDY OF ACUTE LUNG INJURY & ACUTE RESPIRATORY DISTRESS SYNDROME
急性肺损伤的观察性研究
- 批准号:
7603766 - 财政年份:2007
- 资助金额:
-- - 项目类别:
Treatment of Acute Lung Injury and Acute Respiratory Distress Syndrome
急性肺损伤和急性呼吸窘迫综合征的治疗
- 批准号:
8602427 - 财政年份:2005
- 资助金额:
-- - 项目类别:
Treatment of Acute Lung Injury and Acute Respiratory Distress Syndrome
急性肺损伤和急性呼吸窘迫综合征的治疗
- 批准号:
8602351 - 财政年份:2005
- 资助金额:
-- - 项目类别:
Treatment of Acute Lung Injury and Acute Respiratory Distress Syndrome
急性肺损伤和急性呼吸窘迫综合征的治疗
- 批准号:
8654999 - 财政年份:2005
- 资助金额:
-- - 项目类别:
Treatment of Acute Lung Injury and Acute Respiratory Distress Syndrome
急性肺损伤和急性呼吸窘迫综合征的治疗
- 批准号:
8844846 - 财政年份:2005
- 资助金额:
-- - 项目类别:
Treatment of Acute Lung Injury and Acute Respiratory Distress Syndrome
急性肺损伤和急性呼吸窘迫综合征的治疗
- 批准号:
8328484 - 财政年份:2005
- 资助金额:
-- - 项目类别:
Treatment of Acute Lung Injury and Acute Respiratory Distress Syndrome
急性肺损伤和急性呼吸窘迫综合征的治疗
- 批准号:
8328493 - 财政年份:2005
- 资助金额:
-- - 项目类别:
Treatment of Acute Lung Injury and Acute Respiratory Distress Syndrome
急性肺损伤和急性呼吸窘迫综合征的治疗
- 批准号:
8020428 - 财政年份:2005
- 资助金额:
-- - 项目类别: